ICICI Prudential Nifty Pharma Index Fund

ICICI Prudential Mutual Fund · Index Funds (Equity) · Regular Growth · AMFI 150929 · ISIN INF109KC18L6
NAV₹21.427220 Nov 2026
3Y return+20.87%a year
5Y return—a year
Expense ratio1.12%₹177 Cr
Growth Score82.7★★★★★

Returns

1M3M6MYTD1Y3Y5Y7Y10YSince launch
Fund+10.73%+7.20%+14.06%+24.40%+24.44%+20.87%———+21.55%
NIFTY Pharma TRI+10.85%+7.49%+14.67%+25.66%+25.86%+22.31%+16.87%———
Category middle+8.17%-0.17%+5.81%+1.26%+0.50%+10.76%+8.57%+12.10%+12.82%—

Risk (36 months)

Volatility14.94%
Sharpe0.96
Sortino1.57
Beta1.00
Alpha-0.93%
Deepest fall-16.78%
1-year periods with a loss11%
5Y SIP XIRR—

Top holdings (31 Oct 2026)

Sun Pharmaceutical Industries Ltd.18.60%
Divi's Laboratories Ltd.12.28%
Laurus Labs Ltd.9.26%
Dr. Reddy's Laboratories Ltd.8.15%
Cipla Ltd.7.67%
Torrent Pharmaceuticals Ltd.6.71%
Lupin Ltd.4.83%
Aurobindo Pharma Ltd.4.59%
Glenmark Pharmaceuticals Ltd.3.42%
Zydus Lifesciences Ltd.3.05%
Alkem Laboratories Ltd.3.04%
Mankind Pharma Ltd.2.79%

Sectors

Pharmaceuticals & Biotechnology99.9%

Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.